A Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RS-C1001 Tablets in Chinese Healthy Subjects

NCT06669429 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Dyslipidemia

Interventions

DRUG: RS-C1001
DRUG: RS-C1001
DRUG: RS-C1001
DRUG: placebo
DRUG: placebo
DRUG: Placebo

Sponsor

Peking University First Hospital